Skip to content

Fast Brain MRI in Children With Suspected Brain Tumor

Fast Brain MRI in Children With Suspected or Confirmed Brain Tumor

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05776602
Acronym
Fast MRI
Enrollment
32
Registered
2023-03-20
Start date
2023-05-01
Completion date
2025-07-30
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Neoplasms, Brain Neoplasms, Childhood, Brain Tumor, Diagnosis, Image, Magnetic Resonance Imaging, Neuroimaging, Pediatric

Keywords

Neuro, Imaging, MRI, Diagnostic accuracy, Neuroimaging, Fast MRI, Neuromix, Pediatric

Brief summary

This study aims to assess the diagnostic performance of a new fast MRI sequence named Neuromix compared to routine clinical MRI for brain tumor in pediatric patients

Detailed description

The study aims to assess the diagnostic performance of fast MR sequence for the radiological evaluation of brain tumor in comparison to routine clinical MRI (or reference standard) in a pediatric population. The primary outcome is the depiction and characterization of normal brain, brain tumor pathology and incidental findings. Sensitivity, specificity, AUC and intra-/ interreader agreement for the diagnostic performance of Neuromix compared to cMRI will be obtained. Correlation of results between methods will be calculated. Secondary outcomes will also include the assessment of diagnostic image quality and image artifacts. The study population will consist of subjects aged 0-18 with a suspected or diagnosed brain tumor referred for routine MRI examination of the brain. Study subjects will be investigated during the same day at 3T MR with Neuromix sequence in addition to the routine MRI examination. Volume measurements will be compared.

Interventions

DIAGNOSTIC_TESTFast MRI (Neuromix)

Diagnostic performance, correlation, agreement

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age 0-18 years. * Pediatric subjects with diagnosed or suspected brain tumor * Referral routine MRI study.

Exclusion criteria

* MRI planned without sedation * Aborted MR exam * Unstable patient

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic performanceThrough study completion, an average of 1 yearAUC, area under the curve for the comparison of the new method against the reference standard

Secondary

MeasureTime frameDescription
Imaging artifactsthrough study completion, an average of 1 yearImage artifacts on both methods
Imaging qualitythrough study completion, an average of 1 yearImage quality on both methods
Correlationthrough study completion, an average of 1 yearCorrelation between readers and methods
Agreementthrough study completion, an average of 1 yearAgreement between readers and methods
Sensitivitythrough study completion, an average of 1 yearSensitivity of the new method against the reference standard
Specificitythrough study completion, an average of 1 yearSpecificity of the new method against the reference standard

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORAnna Falk Delgado, Ass Prof

Karolinska Institutet

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026